Physicians views on generic medicines: A narrative review

Journal of Generic Medicines

Volumn 7, Issue 1, 2010, Pages 30-39

  Hassali, Mohamed Azmi ^a   Shafie, Asrul Akmal ^a   Awaisu, Ahmed ^a   Ibrahim, Mohamed Izham ^a   Ping, Chong Chee ^a   Jamshed, Shazia ^a  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

Author keywords

Generic medicines; Generic prescribing; Generic substitution; Perceptions; Physicians; Review

Indexed keywords

GENERIC DRUG;

BIOEQUIVALENCE; COST CONTROL; DECISION MAKING; DRUG COST; DRUG SUBSTITUTION; DRUG UTILIZATION; EXPERIENCE; GENERAL PRACTITIONER; MEDICAL PRACTICE; MEDICAL SPECIALIST; PATIENT ATTITUDE; PHYSICIAN; PHYSICIAN ATTITUDE; PRESCRIPTION; REVIEW; SOCIAL ASPECT;

EID: 75949110224     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/jgm.2009.32     Document Type: Review

References (25)

1. Kanavos, P. (1999) Financing pharmaceuticals in transition economies. Croatian Medical Journal 40 (2): 244-259.
2. Ess, S. M., Schneeweiss, S. and Szucs, T. D. (2003) European healthcare policies for controlling drug expenditure. Pharmacoeconomics 21 (2): 89-103.
3. Kirking, D. M. and Ascione, F. J. (2001) Perspectives on generic pharmaceuticals: Some conclusions. Journal of the American Pharmaceutical Association 41 (6): 826-828.
4. Evers, P. (2001) Generics past, present and future. Pharmaceutical Times (October): 30-32.
5. King, D. R. and Kanavos, P. (2002) Encouraging the use of generic medicines: Implications for transition economies. Croatian Medical Journal 43 (4): 462-469.
6. Hassali, M. A., Kong, D. C. and Stewart, K. (2007) A comparison between senior medical students ' and pharmacy pre-registrants ' knowledge and perceptions of generic medicines. Medical Education 41 (7): 703-710.
7. Hellerstein, J. K. (1998) The importance of the physician in the generic versus trade-name prescription decision. Rand Journal of Economics 29 (1): 108-136.
8. Mott, D. A. and Cline, R. R. (2002) Exploring generic drug use behavior: The role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution. Medical Care 40 (8): 662-674.
9. Steinman, M. A., Chren, M. M. and Landefeld, C. S. (2007) What's in a name? Use of brand versus generic drug names in United States outpatient practice. Journal of General Internal Medicine [Brief Reports] 22: 645-648.
10. Muijrers, P. E., Janknegt, R., Sijbrandij, J., Grol, R. P. and Knottnerus, J. A. (2004) Prescribing indicators. Development and validation of guideline-based prescribing indicators as an instrument to measure the variation in the prescribing behaviour of general practitioners. European Journal of Clinical Pharmacology 60 (10): 739-746.
11. Gill, P. S. and Roalfe, A. (2001) Determinants of prescribing costs amongst single-handed general practitioners. Journal of Clinical Pharmacy & Therapeutics 26 (6): 433-435.
12. Bearden, W. O. and Mason, J. B. (1980) Determinants of physician and pharmacist support of generic drugs. Journal of Consumer Research 7 (2): 121-130.
13. Bower, A. D. and Burkett, G. L. (1987) Family physicians and generic drugs: A study of recognition, information sources, prescribing attitudes, and practices. Journal of Family Practice 24 (6): 612-616.
14. Shulkin, D. J. et al (1992) Generic versus brand name drug prescribing by resident physicians in Pennsylvania. American Journal of Hospital Pharmacy 49 (3): 625-626.
15. Banahan 3rd, B. F. and Kolassa, E. M. (1997) A physician survey on generic drugs and substitution of critical dose medications. Archives of Internal Medicine 157 (18): 2080-2088.
16. Barrett, L. L. (2005) Physicians ' Attitudes and Practices Regarding Generic Drugs. Washington DC: AARP Knowledge Management, [updated 2005; cited 11 September 2008], pp. 1-33, http://assets.aarp.org/rgcenter/health/phys- generic.pdf.
17. Hassali, M. A., Kong, D. C. M. and Stewart, K. (2006) Generic medicines perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicines 3 (3): 214-225.
18. Heikkila, R., Mantyselka, P., Hartikainen- Herranen, K. and Ahonen, R. (2007) Customers ' and physicians ' opinions of and experiences with generic substitution during the first year in Finland. Health Policy 82 (3): 366-374.
19. De Run, E. C. and Felix, M.-K. N. (2006) Patented and generic pharmaceutical drugs: Perception and prescription. International Journal of Business and Society 7 (2): 55.
20. Kersnik, J. and Peklar, J. (2006) Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies. Journal of Clinical Pharmacy and Therapeutics 31 (6): 577-583.
21. Paraponaris, A. et al (2004) Delivering generics without regulatory incentives? Empirical evidence from French general practitioners about willingness to prescribe international non-proprietary names. Health Policy 70 (1): 23-32.
22. McGettigan, P., McManus, J., O'Shea, B., Chan, R. and Feely, J. (1997) Low rate of generic prescribing in the Republic of Ireland compared to England and Northern Ireland: Prescribers ' concerns. Irish Medical Journal 90 (4): 146-147.
23. Turnbull, P. W. and Parsons, N. E. (1993) Generic prescribing in general medical practice: An attitudinal study of general practitioners. Marketing Intelligence & Planning 11 (4): 30.
24. Gossell-Williams, M. (2007) Generic substitutions: A 2005 survey of the acceptance and perceptions of physicians in Jamaica. West Indian Medical Journal 56 (5): 458-463.
25. Tilyard, M. W., Dovey, S. M. and Rosenstreich, D. (1990) General practitioners ' views on generic medication and substitution. New Zealand Medical Journal 103 (893): 318-320.